首页> 外国专利> Method for producing the vacuolar cytotoxin protein of Helicobacter pylori from recombinant E. coli

Method for producing the vacuolar cytotoxin protein of Helicobacter pylori from recombinant E. coli

机译:从重组大肠杆菌生产幽门螺杆菌液泡细胞毒素蛋白的方法

摘要

The present invention relates to a method for producing a vacuolar cytotoxin (Vac), which is an antigenic determinant protein of Helicobacter pylori (H. pylori), in the form of a fusion protein using E. coli, Escherichia coli transformed with a Ub-V200 fusion protein expression vector containing a fusion gene in which a ubiquitin gene linked to a gene encoding a protein (V200) consisting of the 168th amino acid to the 367th amino acid of Laurie Vac is subjected to conditions suitable for the expression of the fusion protein , Pulverizing the recombinant E. coli cells expressing the fusion protein, washing the insoluble precipitate with a buffer solution containing triton, dissolving with urea, and performing gel filtration chromatography and heparin-sepharose chromatography Of H. pylori infection according to the method of producing the Ub-V200 fusion protein of the present invention The Ub-V200 fusion protein that can be useful for vaccine development can be mass-produced with high yield.
机译:本发明涉及使用大肠杆菌,用Ub-转化的大肠杆菌生产融合蛋白形式的液泡细胞毒素(Vac)的方法,所述液泡细胞毒素是幽门螺杆菌(H.pylori)的抗原决定簇蛋白。包含融合基因的V200融合蛋白表达载体,其中使泛素基因与编码由Laurie Vac的第168个氨基酸至第367个氨基酸组成的蛋白质(V200)的基因连接,并使其适合于表达融合蛋白的条件,将表达融合蛋白的重组大肠杆菌细胞粉碎,用含有Triton的缓冲溶液洗涤不溶的沉淀,用尿素溶解,并根据幽门螺杆菌感染的产生方法进行凝胶过滤层析和肝素-琼脂糖层析。本发明的Ub-V200融合蛋白可以以高产量大量生产可用于疫苗开发的Ub-V200融合蛋白。领域。

著录项

  • 公开/公告号KR970059276A

    专利类型

  • 公开/公告日1997-08-12

    原文格式PDF

  • 申请/专利权人 성재갑;

    申请/专利号KR19960001197

  • 发明设计人 장호진;유영준;김천형;

    申请日1996-01-20

  • 分类号C12N15/12;

  • 国家 KR

  • 入库时间 2022-08-22 03:16:28

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号